Showing results (631-640 of 678) with videos related to

Sort By:
Pageof 68
Endocrine-Related Cancer|January 22, 2021
Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasmsJames C Yao, Jonathan Strosberg, Nicola Fazio, et al.
Oncotargets and Therapy|March 2, 2016
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinomaAhmed O Kaseb, Jeffrey S Morris, Michiko Iwasaki, et al.
The New England Journal of Medicine|February 11, 2011
Everolimus for advanced pancreatic neuroendocrine tumorsJames C Yao, Manisha H Shah, Tetsuhide Ito, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 yearsJames C Yao, Jennifer F Tseng, Samidha Worah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trialM H Kulke, P Ruszniewski, E Van Cutsem, et al.
Oncology|July 19, 2023
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular CarcinomaShadi Chamseddine, Yehia I Mohamed, Sunyoung S Lee, et al.
Journal of Immunotherapy and Precision Oncology|November 11, 2024
Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular CarcinomaShadi Chamseddine, Betul Gok Yavuz, Yehia I Mohamed, et al.
Gastroenterology|August 3, 2011
Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumorsPuja Gaur, Eric L Sceusi, Shaija Samuel, et al.
Pageof 68